Lombard Odier Asset Management (Switzerland)’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-34,007
| Closed | -$14.2M | – | 351 |
|
2024
Q1 | $14.2M | Sell |
34,007
-2,120
| -6% | -$886K | 1% | 17 |
|
2023
Q4 | $14.7M | Sell |
36,127
-16,729
| -32% | -$6.81M | 1.97% | 12 |
|
2023
Q3 | $18.4M | Sell |
52,856
-4,988
| -9% | -$1.73M | 2.97% | 4 |
|
2023
Q2 | $20.4M | Buy |
57,844
+10,359
| +22% | +$3.65M | 2.89% | 7 |
|
2023
Q1 | $15M | Buy |
47,485
+44,951
| +1,774% | +$14.2M | 1.31% | 23 |
|
2022
Q4 | $732K | Buy |
2,534
+1,192
| +89% | +$344K | 0.06% | 217 |
|
2022
Q3 | $389K | Sell |
1,342
-1,352
| -50% | -$392K | 0.03% | 209 |
|
2022
Q2 | $759K | Buy |
+2,694
| New | +$759K | 0.06% | 176 |
|
2022
Q1 | – | Sell |
-2,229
| Closed | -$489K | – | 390 |
|
2021
Q4 | $489K | Buy |
+2,229
| New | +$489K | 0.03% | 242 |
|
2021
Q3 | – | Sell |
-1,395
| Closed | -$281K | – | 471 |
|
2021
Q2 | $281K | Sell |
1,395
-267
| -16% | -$53.8K | 0.01% | 437 |
|
2021
Q1 | $357K | Buy |
+1,662
| New | +$357K | 0.02% | 286 |
|
2020
Q4 | – | Sell |
-978
| Closed | -$266K | – | 345 |
|
2020
Q3 | $266K | Buy |
+978
| New | +$266K | 0.03% | 315 |
|
2020
Q2 | – | Sell |
-1,058
| Closed | -$252K | – | 325 |
|
2020
Q1 | $252K | Hold |
1,058
| – | – | 0.03% | 300 |
|
2019
Q4 | $232K | Buy |
+1,058
| New | +$232K | 0.02% | 333 |
|
2016
Q2 | – | Sell |
-1,543
| Closed | -$123K | – | 431 |
|
2016
Q1 | $123K | Hold |
1,543
| – | – | 0.01% | 321 |
|
2015
Q4 | $196K | Buy |
+1,543
| New | +$196K | 0.02% | 267 |
|
2015
Q3 | – | Sell |
-1,683
| Closed | -$208K | – | 410 |
|
2015
Q2 | $208K | Sell |
1,683
-897
| -35% | -$111K | 0.02% | 412 |
|
2015
Q1 | $305K | Buy |
2,580
+804
| +45% | +$95K | 0.03% | 323 |
|
2014
Q4 | $212K | Sell |
1,776
-22,142
| -93% | -$2.64M | 0.02% | 383 |
|
2014
Q3 | $2.7M | Buy |
23,918
+21,358
| +834% | +$2.41M | 0.07% | 299 |
|
2014
Q2 | $241K | Buy |
+2,560
| New | +$241K | 0.03% | 340 |
|